A mathematical model of the oral glucose tolerance test illustrating the effects of the incretins

Annals of Biomedical Engineering

Volumn 35, Issue 7, 2007, Pages 1286-1300

  Brubaker, Patricia L ^a   Ohayon, Elan L ^a   D'Alessandro, Lisa M ^a,b   Norwich, Kenneth H ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Computer simulation; Diabetes; GIP; GLP 1; Glucose regulation; Hepatic glucose balance; Insulin; Mathematical model; OGTT

Indexed keywords

COMPUTER SIMULATION; GLUCOSE; HORMONES; MATHEMATICAL MODELS; MEDICAL PROBLEMS; PEPTIDES;

GLUCOSE REGULATION; HEPATIC GLUCOSE BALANCE; ORAL GLUCOSE TOLERANCE TEST (OGTT);

DIAGNOSIS;

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HORMONE; INSULIN;

ARTICLE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; THEORETICAL MODEL;

ADMINISTRATION, ORAL; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HORMONES; HUMANS; INSULIN; MODELS, THEORETICAL;

EID: 34250723395     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-007-9274-1     Document Type: Article

References (56)

1. Ackerman, E., J. W. Rosevear, and W. F. Mcguckin. A mathematical model of the glucose tolerance test. Phys. Med. Biol. 9:203-216, 1964.
2. Antomonov, Y. G., N. K. Gnilitskaya, S. I. Kiforenko, and I. A. Mikulskaya. Mathematical description of the blood sugar system. Math. Biosci. 2:435-450, 1968.
3. Arleth, T., S. Andreassen, M. O. Federici, and M. M. Benedetti. A model of the endogenous glucose balance incorporating the characteristics of glucose transporters. Comput. Methods Programs Biomed. 62:219-234, 2000.
4. Baron, A. D., G. Brechtel, P. Wallace, and S. V. Edelman. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am. J. Physiol. 255:E769-E774, 1988.
5. Basu, A., and R. A. Rizza. Glucose effectiveness: measurement in diabetic and nondiabetic humans. Exp. Clin. Endocrinol. Diabetes 109(Suppl. 2):S157-S165, 2001.
6. Bergman R. N. Lilly lecture. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38:1512-1527, 1989.
7. Bergman, R. N., and M. Ader. Free fatty acids and path-ogenesis of type 2 diabetes mellitus. Trends Endocrinol. Metab. 11:351-356, 2000.
8. Bolli, G., P. De Feo, G. Perriello, S. De Cosmo, M. Ventura, P. Campbell, P. Brunetti, and J. E. Gerich. Role of hepatic autoregulation in defense against hypoglycemia in humans. J. Clin. Invest. 75:1623-1631, 1985.
9. Boston, R. C., P. J. Moate, D. Stefanovski, A. E. Sumner, and R. N. Bergman. AKA-Glucose: a program for kinetic and epidemiological analysis of frequently sampled intravenous glucose tolerance test data using database technology. Diabetes Technol. Ther. 7:298-307, 2005.
10. Brandt, A., M. Katschinski, R. Arnold, K. S. Polonsky, B. Goke, and M. M. Byrne. GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve. Am. J. Physiol. Endocrinol. Metab. 281:E242-E247, 2001.
11. Callegari, T., A. Caumo, and C. Cobelli. Bayesian two-compartment and classic single-compartment minimal models: comparison on insulin modified IVGTT and effect of experiment reduction. IEEE Trans. Biomed. Eng. 50:1301-1309, 2003.
12. Cerasi, E., S. Ependic, and R. Luft. Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects. Lancet 1:794-797, 1973.
13. Charette, W. P., A. H. Kadish, and R. Sridhar. Modeling and control aspects of glucose homeostasis. Math. Biosci. 3 (Suppl. 1):115-149, 1969.
14. Cherrington, A. D. Banting Lecture. Control of glucose uptake and release by the liver in vivo. Diabetes 48:1198-1214, 1997.
15. Chiasson, J. L., G. G. el Achkar, F. Ducros, J. Bourque, and P. Maheux. Glucose turnover and gluconeogenesis during pregnancy in women with and without insulin-dependent diabetes mellitus. Clin. Invent. Med. 20:140-151, 1997.
16. Connolly, C. C., B. A. Adkins-Marshall, D. W. Neal, W. Pugh, J. B. Jaspan, and A. D. Cherrington. Relationship between decrements in glucose level and metabolic response to hypoglycemia in absence of counterregulatory hormones in the conscious dog. Diabetes 41:1308-1319, 1992.
17. Creutzfeldt, W. The [pre-] history of the incretin concept. Regul. Pept. 128:87-91, 2005.
18. Dalla Man, C., A. Caumo, R. Basu, R. Rizza, G. Toffolo, and C. Cobelli. Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. Am. J. Physiol. Endocrinol. Metab. 287:E637-E643, 2004.
19. de Herder, W. W. Insulinoma. Neuroendocrinology 80(Suppl 1):20-22, 2004.
20. DeFronzo, R. A., R. Gunnarsson, O. Bjorkman, M. Olsson, and J. Wahren. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J. Clin. Invest. 76:149-155, 1985.
21. Drucker, D. J. Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes. Expert. Opin. Investig. Drugs 12:87-100, 2003.
22. Dube, P. E., and P. L. Brubaker. Nutrient, neural and endocrine control of glucagon-like peptide secretion. Horm. Metab. Res. 36:755-760, 2004.
23. Duckworth, W. C. Insulin degradation: mechanisms, products, and significance. Endocr. Rev. 9:319-345, 1988.
24. Fehse, F., M. Trautmann, J. J. Holst, A. E. Halseth, N. Nanayakkara, L. L. Nielsen, M. S. Fineman, D. D. Kim, and M. A. Nauck. Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. J. Clin. Endocrinol. Metab. 90:5991-5997, 2005.
25. Ferrannini, E., O. Bjorkman, G. A. Reichard Jr., A. Pilo, M. Olsson, J. Wahren, and R. A. DeFronzo. The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes 34:580-588, 1985.
26. Ferrannini, E., D. C. Simonson, L. D. Katz, G. Reichard Jr., S. Bevilacqua, E. J. Barrett, M. Olsson, and R. A. DeFronzo. The disposal of an oral glucose load in patients with noninsulin-dependent diabetes. Metabolism 37:79-85, 1988.
27. Ferrannini, E., J. D. Smith, C. Cobelli, G. Toffolo, A. Pilo, and R. A. DeFronzo. Effect of insulin on the distribution and disposition of glucose in man. J. Clin. Invest. 76:357-364, 1985.
28. Forbath, N., and G. Hetenyi, Jr. Glucose dynamics in normal subjects and diabetic patients before and after a glucose load. Diabetes 15:778-789, 1966.
29. Gatewood, L. C., E. Ackerman, J. W. Rosevear, G. D. Molnar, and T. W. Burns. Tests of a mathematical model of the blood-glucose regulatory system. Comput. Biomed. Res. 2:1-14, 1968.
30. Giacca, A., Y. Groenewoud, E. Tsui, P. McClean, and B. Zinman. Glucose production, utilization, and cycling in response to moderate exercise in obese subjects with type 2 diabetes and mild hyperglycemia. Diabetes 47:1763-1770, 1998.
31. Hayford, J. T., J. A. Weydert, and R. G. Thompson. Validity of urine glucose measurements for estimating plasma glucose concentration. Diabetes Care 6:40-44, 1983.
32. Hetenyi, G. Jr., B. Pagurek, G. Fluker, J. Anthony, I. Popescu, and K. H. Norwich. Computer controlled glucoregulation in the diabetic dog. Ann. Biomed. Eng. 5:61-69, 1977.
33. Kahn, S. E., R. L. Prigeon, D. K. McCulloch, E. J. Boyko, R. N. Bergman, M. W. Schwartz, J. L. Neifing, W. K. Ward, J. C. Beard, and J. P. Palmer. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672, 1993.
34. Kleinbaum, J., and H. Shamoon. Selective counterregulatory hormone responses after oral glucose in man. J. Clin. Endocrinol. Metab. 55:787-790, 1982.
35. Kolterman, O. G., R. S. Gray, J. Griffin, P. Burstein, J. Insel, J. A. Scarlett, and J. M. Olefsky. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J. Clin. Invest. 68:957-969, 1981.
36. Lewis, G. F., G. Steiner, K. S. Polonsky, B. Weller, and B. Zinman. A new method for comparing portal and periph eral venous insulin delivery in humans: tolbutamide versus insulin infusion. J. Clin. Endocrinol. Metab. 79:66-70, 1994.
37. Mari, A., G. Pacini, E. Murphy, B. Ludvik, and J. J. Nolan. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539-548, 2001.
38. Mayer-Davis, E. J., R. D'Agostino, Jr., A. J. Karter, S. M. Haffner, M. J. Rewers, M. Saad, and R. N. Bergman. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. J. Am. med. Assoc. 279:669-674, 1998.
39. Meier, J. J., M. A. Nauck, D. Kranz, J. J. Holst, C. F. Deacon, D. Gaeckler, W. E. Schmidt, and B. Gallwitz. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects. Diabetes 53:654-662, 2004.
40. Miedema, K. Laboratory tests in diagnosis and management of diabetes mellitus. Practical considerations. Clin. Chem. Lab. Med 41:1259-1265, 2003.
41. Moore, M. C., A. D. Cherrington, and D. H. Wasserman. Regulation of hepatic and peripheral glucose disposal. Best. Pract. Res. Clin. Endocrinol. Metab. 17:343-364, 2003.
42. Nauck, M. A., E. Hornberger, E. G. Siegel, R. C. Allen, R. P. Eaton, R. Ebert, and W. Creutzfeldt. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J. Clin. Endocrinol. Metab. 63:492-498, 1986.
43. Norwich, K. H. Molecular Dynamics in Biosystems: The Kinetics of Tracers in Intact Organisms. Oxford: Pergamon Press, pp. 326, 1977.
44. Perley, M. J., and D. M. Kipnis. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J. Clin. Invest. 46:1954-1962, 1967.
45. Potteiger, J. A., D. J. Jacobsen, J. E. Donnelly, and J. O. Hill. Glucose and insulin responses following 16 months of exercise training in overweight adults: the Midwest Exercise Trial. Metabolism 52:1175-1181, 2003.
46. Quon, M. J., C. Cochran, S. I. Taylor, and R. C. Eastman. Direct comparison of standard and insulin modified protocols for minimal model estimation of insulin sensitivity in normal subjects. Diabetes Res. 25:139-149, 1994.
47. Radziuk, J., K. H. Norwich, and M. Vranic. Experimental validation of measurements of glucose turnover in non-steady state. Am. J. Physiol. Endocrinol. Metab. 234:E84-E93, 1978.
48. Rice, F. O., and K. F. Herzfeld. The thermal decomposition of organic compounds from the standpoint of free radicals. VI. The mechanism of some chain reactions. J. Am.Chem. Soc. 56:284-289, 1934.
49. Salzsieder, E., G. Albrecht, U. Fischer, and E. J. Freyse. Kinetic modeling of the glucoregulatory system to improve insulin therapy. IEEE. Trans. Biomed. Eng. 32:846-855, 1985.
50. Schirra, J., M. Katschinski, C. Weidmann, T. Schafer, U. Wank, R. Arnold, and B. Goke. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J. Clin. Invest. 97:92-103, 1996.
51. Sluiter, W. J., D. W. Erkelens, W. D. Reitsma, and H. Doorenbos. Glucose tolerance and insulin release, a mathematical approach I. Assay of the beta-cell response after oral glucose loading. Diabetes 25:241-244, 1976.
52. Sluiter, W. J., D. W. Erkelens, P. Terpstra, W. D. Reitsma, and H. Doorenbos. Glucose tolerance and insulin release, a mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes 25:245-249, 1976.
53. Thomaseth, K., A. Kautzky-Willer, B. Ludvik, R. Prager, and G. Pacini. Integrated mathematical model to assess beta-cell activity during the oral glucose test. Am. J. Physiol. 270:E522-E531, 1996.
54. Vilsboll, T., T. Krarup, S. Madsbad, and J. J. Holst. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Reg. Pep. 114:115-121, 2003.
55. Wright, E. M., M. G. Martin, and E. Turk. Intestinal absorption in health and disease-sugars. Best. Pract. Res. Clin. Gastroenterol. 17:943-956, 2003.
56. Yang, Y. J., I. D. Hope, M. Ader, and R. N. Bergman. Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose. Am. J. Physiol. 266:E17-E25, 1994.